Targeted biologics Position ProteinMentor as a turnkey platform for pre-clinical candidate screening and comparability assessment to accelerate development timelines for biopharma clients seeking faster pathways to clinic and market.

Quality and ICHQ5E Highlight compliance and robustness benefits by emphasizing support for ICH Q5E-guided process changes, batch-to-batch comparability, and high-concentration testing to reduce regulatory risk and ensure product quality.

High-throughput advantage Advise sales teams to target sponsors needing multiplexed CQA evaluation, self-association, aggregation, deamidation, glycosylation, stability, and epitope mapping to streamline lead optimization and go/no-go decisions.

Cloud and data integrity Leverage the cloud-ready, 21 CFR 11 compliant platform to offer secure data management, audit-ready analytics, and reproducible results as a differentiator for partnerships with risk-averse sponsors.

Strategic funding alignment Tap into potential opportunities with small to mid-sized biopharma firms and early-stage programs highlighted by prior NSF SBIR support and recent platform launch to secure pilot collaborations and proof-of-concept studies.